Research Partnership

A partnership to help support the growing evidence for medical cannabis treatment

Imperial College London, leading the groundbreaking medical cannabis research group in the UK

EMMAC Life Sciences has entered into a research collaboration with Imperial College London, involving the pre-clinical and clinical evaluation of cannabis-derived medicinal products including a feasibility randomised controlled trial for the treatment of perioperative pain, nausea and vomiting in major hepatopancreatobiliary surgery.

The aims of the project are to:

1. Investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer through in vitro and in vivo work 

2. Develop a clinical trial protocol for a feasibility randomised controlled trial and undertake necessary tasks related to regulatory pathways and subsequent practical elements of setting up and running such trial  

3. Characterise cannabis-based medicinal products in disease models with particular focus on chronic pain, spasticity and cancer

Join our Partnership Scheme to deliver the future of Medical Cannabis

Fill out our form to apply for our Partnership Scheme or send us an email to [email protected].